Bristol Myers Squibb Income Statement (2009-2026) | BMY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	11.70B	11.62B	11.98B	11.65B	11.89B	11.22B	11.41B	11.34B	11.23B	10.97B	11.48B	11.87B	12.20B	11.89B	12.34B	11.20B	12.27B	12.22B	12.50B	11.49B
Cost of Revenue (Quarter)	2.45B	2.29B	2.36B	2.47B	2.72B	2.35B	2.59B	2.57B	2.88B	2.51B	2.75B	2.93B	3.27B	2.96B	4.81B	3.03B	3.37B	3.44B	4.10B	3.42B
Gross Profit (Quarter)	9.25B	9.33B	9.63B	9.18B	9.17B	8.87B	8.81B	8.77B	8.35B	8.46B	8.73B	8.93B	8.93B	8.94B	7.53B	8.17B	8.90B	8.79B	8.40B	8.07B
Operating items
Amortization - Intangibles (Quarter)	2.55B	2.55B	2.42B	2.42B	2.42B	2.42B	2.34B	2.26B	2.26B	2.26B	2.28B	2.36B	2.42B	2.41B	1.69B	0.83B	0.83B	0.83B	0.83B	0.44B
Research & Development (Quarter)	2.48B	2.98B	2.52B	2.26B	2.32B	2.42B	2.51B	2.32B	2.26B	2.24B	2.48B	2.69B	2.90B	2.37B	3.19B	2.26B	2.58B	2.53B	2.59B	2.65B
Selling, General & Administrative (Quarter)	1.88B	1.79B	2.35B	1.83B	1.79B	1.93B	2.27B	1.76B	1.93B	2.00B	2.07B	2.37B	1.93B	1.98B	2.14B	1.58B	1.71B	1.79B	2.18B	1.62B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	5.79B	4.70B	5.25B	5.87B	5.82B	4.66B	4.77B	4.48B	5.17B	4.58B	5.25B	18.32B	6.09B	5.86B	6.84B	4.39B	6.20B	4.79B	6.26B	3.98B
Operating Expenses (Quarter)	10.15B	9.47B	10.13B	9.96B	9.93B	9.01B	9.55B	8.57B	9.37B	8.83B	9.80B	23.38B	10.91B	10.22B	12.17B	8.23B	10.50B	9.11B	11.03B	8.25B
Operating Income (Quarter)	-0.90B	-0.13B	-0.50B	-0.78B	-0.76B	-0.14B	-0.73B	0.20B	-1.02B	-0.37B	-1.07B	-14.45B	-1.98B	-1.28B	-4.64B	-0.06B	-1.60B	-0.32B	-2.63B	-0.18B
EBIT (Quarter)	-0.90B	-0.13B	-0.50B	-0.78B	-0.76B	-0.14B	-0.73B	0.20B	-1.02B	-0.37B	-1.07B	-14.45B	-1.98B	-1.28B	-4.64B	-0.06B	-1.60B	-0.32B	-2.63B	-0.18B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.00B	0.41B	-0.39B	-0.65B	-0.28B	0.14B	0.22B	0.41B	0.12B	0.26B	0.37B	-0.08B	-0.27B	-0.23B	-0.30B	-0.34B	-0.49B	0.11B	0.05B	-0.03B
Non Operating Income (Quarter)	0.00B	0.41B	-0.39B	-0.65B	-0.28B	0.14B	0.22B	0.41B	0.12B	0.26B	0.37B	-0.08B	-0.27B	-0.23B	-0.30B	-0.34B	-0.49B	0.11B	0.05B	-0.03B
Net income details
EBT (Quarter)	1.55B	2.16B	1.86B	1.69B	1.96B	2.21B	1.86B	2.77B	1.86B	2.14B	1.67B	-11.52B	1.29B	1.68B	0.17B	2.97B	1.77B	3.11B	1.47B	3.24B
Tax Provisions (Quarter)	0.49B	0.60B	-0.51B	0.40B	0.53B	0.60B	-0.17B	0.50B	-0.22B	0.20B	-0.09B	0.39B	-0.40B	0.46B	0.10B	0.51B	0.46B	0.92B	0.38B	0.56B
Profit After Tax (Quarter)	1.05B	1.55B	2.39B	0.01B	1.42B	1.61B	2.04B	0.01B	0.00B	1.93B	1.76B	-11.91B	1.68B	1.22B	0.06B	2.46B	0.00B	2.20B	1.08B	2.68B
Equity Income (Quarter)		0.04B							-0.01B	0.02B			0.03B	-0.02B
Net Income - Minority (Quarter)	-0.07B	-0.07B									-0.06B		-0.05B	-0.06B
Income from Non-Controlling Interests (Quarter)	0.01B	0.01B		0.01B	0.01B	0.00B	0.00B	0.01B	0.00B	0.01B		0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	-0.01B	-0.00B	0.00B
Income from Continuing Operations (Quarter)	1.06B	1.55B	2.37B	1.28B	1.43B	1.61B	2.02B	2.27B	2.08B	1.93B	1.76B	-11.91B	1.68B	1.22B	0.08B	2.46B	1.31B	2.19B	1.09B	2.68B
Consolidated Net Income (Quarter)	1.06B	1.55B	2.37B	1.28B	1.43B	1.61B	2.02B	2.27B	2.08B	1.93B	1.76B	-11.91B	1.68B	1.22B	0.08B	2.46B	1.31B	2.19B	1.09B	2.68B
Income towards Parent Company (Quarter)	0.99B	1.48B	2.37B	1.28B	1.43B	1.61B	2.02B	2.27B	2.08B	1.93B	1.71B	-11.91B	1.63B	1.16B	0.08B	2.46B	1.31B	2.19B	1.09B	2.68B
Net Income towards Common Stockholders (Quarter)	0.99B	1.48B	2.37B	1.28B	1.43B	1.61B	2.02B	2.27B	2.08B	1.93B	1.71B	-11.91B	1.63B	1.16B	0.08B	2.46B	1.31B	2.19B	1.09B	2.68B
Additional items
EPS (Basic) (Quarter)	0.47	0.70	1.07	0.60	0.67	0.75	0.96	1.08	0.99	0.94	0.87	-5.89	0.83	0.60	0.04	1.21	0.64	1.08	0.54	1.31
EPS (Weighted Average and Diluted) (Quarter)	0.47	0.69	1.07	0.59	0.66	0.75	0.95	1.07	0.99	0.93	0.87	-5.89	0.83	0.60	0.04	1.20	0.64	1.08	0.53	1.31
Shares Outstanding (Weighted Average) (Quarter)	2.23B	2.22B	2.22B	2.15B	2.13B	2.14B	2.13B	2.10B	2.09B	2.06B	2.07B	2.02B	2.03B	2.03B	2.03B	2.03B	2.04B	2.03B	2.03B	2.04B
EBITDA (Quarter)	1.08B	1.64B	2.53B	1.32B	1.66B	1.76B	1.58B	2.17B	2.05B	2.03B	1.50B	-11.77B	1.62B	1.20B	0.30B	2.27B	1.18B	2.24B	1.07B	2.83B
Interest Expenses (Quarter)
Tax Rate (Quarter)	31.68%	28.05%	-27.66%	23.95%	27.02%	27.21%	-8.93%	18.16%	-11.73%	9.50%	-5.26%	-3.40%	-30.95%	27.51%	56.57%	17.13%	25.94%	29.51%	26.12%	17.31%

Research Tools

Bristol Myers Squibb Income Statement (2009-2026) | BMY

Create an account

Sign In

Reset Password